Serum alpha-CGRP levels are increased in COVID-19 patients with headache indicating an activation of the trigeminal system

[1]  M. Toriello,et al.  Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients , 2022, Archives of Medical Research.

[2]  A. Gursoy,et al.  Is Persistent Post-COVID Headache Associated With Protein-Protein Interactions Between Antibodies Against Viral Spike Protein and CGRP Receptor?: A Case Report , 2022, Frontiers in Pain Research.

[3]  J. Crespo,et al.  Increase in Serum Calcitonin Gene-Related Peptide β (CGRPβ) Levels in COVID-19 Patients with Diarrhea: An Underlying Mechanism? , 2022, Digestive Diseases and Sciences.

[4]  D. García‐Azorín,et al.  Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients , 2022, Cephalalgia : an international journal of headache.

[5]  P. Pozo‐Rosich,et al.  Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks , 2021, Cephalalgia : an international journal of headache.

[6]  K. Messlinger,et al.  Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 , 2021, Cephalalgia : an international journal of headache.

[7]  Á. G. Guerrero Peral,et al.  Frequency and phenotype of headache in covid-19: a study of 2194 patients , 2021, Scientific Reports.

[8]  H. Bolay,et al.  HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism , 2021, The Journal of Headache and Pain.

[9]  G. Coppola,et al.  How does the brain change in chronic migraine? Developing disease biomarkers , 2020, Cephalalgia : an international journal of headache.

[10]  D. Kaya,et al.  Reader response: Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry , 2020 .

[11]  J. Álvarez-Sabín,et al.  Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution , 2020, Cephalalgia : an international journal of headache.

[12]  P. Rocha-Filho,et al.  Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia , 2020, Cephalalgia : an international journal of headache.

[13]  M. Fowkes,et al.  Circulating levels of calcitonin gene-related peptide (CGRP) are lower in COVID-19 patients , 2020, medRxiv.

[14]  H. Bolay,et al.  COVID‐19 is a Real Headache! , 2020, Headache.

[15]  Carrie E. Robertson,et al.  Could CGRP Antagonists Be Helpful in the Fight Against COVID‐19? , 2020, Headache.

[16]  T. Sobrino,et al.  CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study , 2018, Headache.

[17]  Thomas Hankemeier,et al.  Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis , 2017, Cephalalgia : an international journal of headache.

[18]  P. Martínez-Camblor,et al.  Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine , 2013, Neurology.

[19]  P. Goadsby,et al.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache , 1990, Annals of neurology.